SEARCH

SEARCH BY CITATION

References

  • American Medical Association. (2001) Managing Osteoporosis: Update in Patient Management. American Medical Association, Chicago, IL, USA.
  • Atalay, B., Caner, H., Gokce, C. & Altinors, N. (2005) Kyphoplasty: 2 years of experience in a neurosurgery department. Surgical Neurology, 64(Suppl. 2), S72S76.
  • Bagan, J., Blade, J., Corzar, J.M., Constela, M., García Sanz, R., Gómez Veiga, F., Lahuerta, J.J., Lluch, A., Massuti, B., Morote, J., San Miguel, J.F. & Solsona, E. (2007) Recommendations for the prevention, diagnosis and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates. Medicina oral, patología oral y cirugía bucal, 12, E336E340.
  • Barrett-Connor, E., Siris, E.S., Wehren, L.E., Miller, P.D., Abbott, T.A., Berger, M.L., Santora, A.C. & Sherwood, L.M. (2005) Osteoporosis and fracture risk of women of different ethnic groups. Journal of Bone and Mineral Research, 20, 185194.
  • Berenson, J., Yellin, O., Boccia, R.V., Flam, M., Wong, S.F., Batuman, O., Moezi, M.M., Woytowitz, D., Duvivier, H., Nassir, Y. & Swift, R.A. (2008) Zoledronic acid markedly improves bone mineral density for patients with monoclonal gammopathy of undetermined significance and bone loss. Clinical Cancer Research, 14, 62896295.
  • Berenson, J.R., Pflugmacher, R., Jarzem, P., Zonder, J.A., Tillman, J.B., Ashraf, T. & Vrionis, F. (2009) Final results of the first randomized trial comparing balloon kyphoplasty (BKP) to non-surgical management among cancer patients with vertebral compression fractures: marked improvement in back function, quality of life and pain in the BKP arm. Blood (American Society of Hematology Annual Meeting Abstracts), 114: Abstract abstract #2873.
  • Bianchi, G., Vitali, G., Caraceni, A., Ravaglia, S., Capri, G., Cundari, S., Zanna, C. & Gianni, L. (2005) Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine. European Journal of Cancer, 41, 17461750.
  • Bida, J.P., Kyle, R.A., Therneau, T.M., Melton, L.J. III, Plevak, M.F., Larson, D.R., Dispenzieri, A., Katzmann, J.A. & Rajkumar, S.V. (2009) Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clinic Proceedings, 84, 685693.
  • Black, D.M., Schwartz, A.V., Ensrud, K.E., Cauley, J.A., Levis, S., Quandt, S.A., Satterfield, S., Wallace, R.B., Bauer, D.C., Palermo, L., Wehren, L.E., Lombardi, A., Santora, A.C. & Cummings, S.R. (2006) Effects of continuing or stopping alendronate after 5 years of treatment- The Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA, 296, 29272938.
  • Bladé, J. (2006) Monoclonal Gammopathy of Undetermined Significance. New England Journal of Medicine, 355, 27652770.
  • Bradwell, A.R., Carr-Smith, H.D., Mead, G.P., HHarvey, T.C. & Drayson, M.T. (2003) Serum test for assessment of patients with Bence Jones myeloma. Lancet, 361, 489491.
  • Brufsky, A., Harker, W.G., Beck, J.T., Carroll, R., Tan-Chiu, E., Seidler, C., Hohneker, J., Lacerna, L., Petrone, S. & Perez, E.A. (2007) Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer. Journal of Clinical Oncology, 25, 829836.
  • Buchbinder, R., Osborne, R.H., Ebeling, P.R., Wark, J.D., Mitchell, P., Wriedt, C., Graves, S., Staples, M.P. & Murphy, B. (2009) A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. New England Journal of Medicine, 361, 557568.
  • Cantor, K.P. & Blair, A. (1984) Farming and mortality from multiple myeloma: a case-control study with the use of death certificates. Journal of the National Cancer Institute, 72, 251255.
  • Capsaicin Study Group (1992) Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care, 15, 159165.
  • Chiras, J., Depriester, C., Weill, A., Sola-Martinez, M.T. & Deramond, H. (1997) Percutaneous vertebral surgery. Techniques and indications. Journal of Neuroradiology. Journal de Neuroradiologie, 24, 4559.
  • Cohen, H.J. (2006) Prevalence of monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 354, author reply 2832.
  • Cornblath, D.R., McArthur, J.C., Kennedy, P.G.E., Witte, A.S. & Griffin, J.W. (1987) Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Annals of Neurology, 21, 3240.
  • Drappatz, J. & Batchelor, T. (2004) Neurologic Complications of Plasma Cell Disorders. Clinical lymphoma, 5, 163171.
  • Dyck, P.J., Low, P.A., Windebank, A.J., Jaradeh, S.S., Gosselin, S., Bourque, P., Smith, B.E., Kratz, K.M., Karnes, J.L. & Evans, B.A. (1991) Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 325, 14821486.
  • Ettinger, B., Black, D.M., Mitlak, B.E., Knickerbocker, R.K., Nickelsen, T., Genant, H.K., Christiansen, C., Delmas, P.D., Zanchetta, J.R., Stakkestad, J., Gluer, C.C., Krueger, K., Cohen, F.J., Eckert, S., Ensrud, K.E., Avioli, L.V., Lips, P. & Cummings, S.R. (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA, 282, 637645.
  • Gloth, F.M., Gundberg, C.M., Hollis, B.W., Haddad, Jr, J.G. & Tobin, J.D. (1995) Vitamin D Deficiency in Homebound Elderly Persons. JAMA, 274, 16831686.
  • Gosselin, S., Kyle, R.A. & Dyck, P.J. (1991) Neuropathy associated with monoclonal gammopathies of undetermined significance. Annals of Neurology, 30, 5461.
  • Gregersen, H., Jensen, P., Gislum, M., Jørgensen, B., Sørensen, H.T. & Nørgaard, M. (2006) Fracture risk in patients with monoclonal gammopathy of undetermined significance. British Journal of Haematology, 135, 6267.
  • Harrington, J.T., Ste-Marie, L.-G., Brandi, M.L., Civitelli, R., Fardellone, P., Grauer, A., Barton, I. & Boonen, S. (2004) Risedronate rapidly reduced the risk for nonvertebral fractures in women with postmenopausal osteoporosis. Calcified Tissue International, 74, 129135.
  • Haupt, E., Ledermann, H. & Köpcke, W. (2005) Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study). International Journal of Clinical Pharmacology and Therapeutics, 43, 7177.
  • Hulme, P.A., Krebs, J., Ferguson, S.J. & Berlemann, U. (2006) Vertebroplasty and kyphoplasty: a systematic review of 69 clinical studies. Spine, 31, 19832001.
  • Ide, H., Fujiya, S., Asanuma, Y., Tsuji, M., Sakai, H. & Agishi, Y. (1987) Clinical usefulness of intrathecal injection of methylcobalamin in patients with diabetic neuropathy. Clinical Therapeutics, 9, 183192.
  • International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. British Journal of Haematology, 121, 749757.
  • Iwanaga, M., Tagawa, M., Tsukansaki, K., Kamihira, S. & Tomonaga, M. (2007a) Prevalence of monoclonal gammopathy of undetermined significance: study of 52 802 persons in Nagasaki City, Japan. Mayo Clinic Proceedings, 82, 14741479.
  • Iwanaga, M., Tagawa, M., Tsukansaki, K., Matsuo, T., Yokota, K.-I., Miyazaki, Y., Fukushima, T., Hata, T., Imaizumi, Y., Imanishi, D., Taguchi, J., Momita, S., Kamihira, S. & Tomonaga, M. (2007b) Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors. Blood, 113, 16391650.
  • Jakob, C., Zavrski, I., Heider, U., Brux, B., Eucker, J., Langelotz, C., Sinha, R., Possinger, K. & Sezer, O. (2002) Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma. European Journal of Haematology, 69, 3742.
  • Kallmes, D.F., Comstock, B.A., Heagerty, P.J., Turner, J.A., Wilson, D.J., Diamond, T.H., Edwards, R., Gray, L.A., Stout, L., Owen, S., Hollingworth, W., Ghdoke, B., Annesley-Williams, D.J., Ralston, S.H. & Jarvik, J.G. (2009) A randomized trial of vertebroplasty for osteoporotic spinal fractures. New England Journal of Medicine, 361, 569579.
  • Kelly, Jr, J.J.. (1985) Peripheral neuropathies associated with monoclonal proteins: a clinical review. Muscle and Nerve, 8, 138150.
  • Kelly, J.J., Kyle, R.A., O’Brien, P.C. & Dyck, P.J. (1981) Prevalence of monoclonal protein in peripheral neuropathy. Neurology, 31, 14801483.
  • Kissel, J.T. & Mendell, J.R. (1995) Neuropathies associated with monoclonal gammopathies. Neuromuscular disorders, 6, 318.
  • Kristinsson, S.Y., Fears, T.R. & Gridley, G. (2008) Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Blood, 112, 35823586.
  • Kumar, S., Rajkumar, S.V., Kyle, R.A., Lacy, M.Q., Dispenzieri, A., Fonseca, R., List, J.A., Gertz, M.A., Greipp, P.R. & Witzig, T.E. (2005) Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance. Journal of Clinical Oncology, 23, 56685674.
  • Kyle, R.A. (1978) Monoclonal gammopathy of undetermined significance: natural history in 241 cases. American Journal of Medicine, 64, 814826.
  • Kyle, R.A. (1984) ‘Benign’ monoclonal gammopathy: a misnomer? JAMA, 251, 18491854.
  • Kyle, R.A. & Dyck, P.J. (1993) Neuropathy associated with monoclonal gammopathies. In: Peripheral Neuropathy, 3rd edn. (ed. by P.J.Dyck, P.K.Thomas, J.W.Griffin, P.A.Low & J.F.Podulos), 12751287. WB Saunders, Philadelphia.
  • Kyle, R.A., Therneau, T.M., Rajkumar, S.V., Offord, J.R., Larson, D.R., Plevak, M.F. & Melton, L.J. III (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 346, 564569.
  • Kyle, R.A., Therneau, T.M., Rajkumar, S.V., Larson, D.R., Plevak, M.F. & Melton, L.J. III (2004) Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clinic Proc, 79, 859866.
  • Kyle, R.A., Therneau, T.M., Rajkumar, S.V., Larson, D.R., Plevak, M.F., Offord, J.R., Dispernzieri, A., Katzmann, J.A. & Melton, L.J. (2006) Prevalence of monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 354, 13621369.
  • Landgren, O. & Weiss, B. (2009) Patterns of monoclonal gammopathy and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis. Leukemia, 23, 16911697.
  • Landgren, O., Gridley, G., Turesson, I., Caporaso, N.E., Goldin, L.R., Baris, D., Fears, T.R., Hoover, R.N. & Linet, M.S. (2006) Risk of monoclonal gammopathy of undetermined significance and subsequent multiple myeloma among African American and white veterans in the United States. Blood, 107, 904906.
  • Landgren, O., Kyle, R.A., Pfeiffer, R.M., Katzmann, J.A., Caporaso, N.E., Hayes, R.B., Dispenzieri, A., Kumar, S., Clark, R.J., Baris, D., Hoover, R. & Rajkumar, S.V. (2009a) Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood, 113, 54125417.
  • Landgren, O., Kyle, R.A., Hoppin, J.A., Beane Freeman, L.E., Cerhan, J.R., Katzmann, J.A., Rajkumar, S.V. & Alavanja, M.C. (2009b) Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study. Blood, 113, 63866391.
  • Lieberman, U.A., Weiss, S.R. & Broll, J. (1995) Effect of three years’ treatment with oral alendronate on bone mineral density and fracture incidence in women with postmenopausal osteoporosis. New England Journal of Medicine, 333, 14371443.
  • Lieberman, I.H., Dudeney, S., Reinhardt, M.K. & Bell, G. (2001) Initial outcome and efficacy of “kyphoplasty” in the treatment of painful osteoporotic vertebral compression fractures. Spine, 26, 16311638.
  • Maestri, A., De Pasquale Ceratti, A., Cundari, S., Zanna, C., Cortesi, E. & Crinò, L. (2005) A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy. Tumori, 91, 135138.
  • McClung, M.R., Lewiecki, E.M., Cohen, S.B., Bolognese, M.A., Woodson, G.C., Moffett, A.H., Peacock, M., Miller, P.D., Lederman, S.N., Chesnut, C.H., Lain, D., Kivitz, A.J., Holloway, D.L., Zhang, Z., Peterson, M.C. & Bekker, P.J. (2006) Denosumab in postmenosausal women with low bone mineral density. New England Journal of Medicine, 354, 821831.
  • Melmed, C., Frail, D., Duncan, I., Braun, P., Danoff, D., Finlayson, M. & Stewart, J. (1983) Peripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein. Neurology, 33, 13971405.
  • Melton, III, L.J., Rajkumar, S.V., Khosla, S., Achenbach, S.J., Oberg, A.L. & Kyle, R.A. (2004) Fracture risk in monoclonal gammopathy of undetermined significance. Journal of Bone and Mineral Research, 19, 2530.
    Direct Link:
  • Omdahl, J.L., Garry, P.J., Hunsaker, L.A., Hunt, W.C. & Goodwin, J.S. (1982) Nutritional status in a healthy elderly population: vitamin D. American Journal of Clinical Nutrition, 36, 12251233.
  • Orsini, E.C., Byrick, R.J., Mullen, J.B., Kay, J.C. & Waddell, J.P. (1987) Cardiopulmonary function and pulmonary microemboli during arthroplasty using cemented of non-cemented components. The role of intramedullary pressure. Journal of Bone and Joint Surgery. American Volume, 69, 822832.
  • Overgaard, K., Hansen, M.A., Jensen, S.B. & Christiansen, C. (1992) Effect of calcitonin given postnasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ, 305, 556561.
  • Padovani, B., Kasriel, O., Brunner, P. & Peretti-Viton, P. (1999) Pulmonary embolism caused by acrylic cement: a rare complication of percutaneous vertebroplasty. AJNR. American Journal of Neuroradiology, 20, 375377.
  • Pepe, J., Petrucci, M.T., Nofroni, I., Fassino, V., Diacinti, D., Romagnoli, E. & Minisola, S. (2006) Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. British Journal of Haematology, 134, 485490.
  • Pepe, J., Petrucci, M.T., Mascia, M.L., Piemonte, S., Fassino, V., Romagnoli, E. & Minisola, S. (2008) The effects of alendronate treatment in osteoporotic patients affected by monoclonal gammopathy of undetermined significance. Calcified Tissue International, 82, 418426.
  • Pérez-Persona, E., Vidriales, M.B., Mateo, G., García-Sanz, R., Mateos, M.-V., García de Coca, A., Galende, J., Martín-Nuñez, G., Alonso, J.M., De Las Heras, N., . Hernández, J.M., Martín, A., López-Berges, C., Orfao, A. & San Miguel, J.F. (2007) New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells. Blood, 110, 25862592.
  • Pinto, P.W. (1993) Cardiovascular collapse associated with the use of methylmethacrylate. American Association of Nurse Anesthetists Journal, 61, 613616.
  • Politou, M., Terpos, E., Anagnostopoulos, A., Szydlo, R., Laffan, M., Layton, M., Apperley, J.F., Dimopoulos, M.A. & Rahemtull, A. (2004) Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS). British Journal of Haematology, 126, 686689.
  • Rajkumar, S.V., Kyle, R.A., Therneau, T.M., Melton, L.J. III, Bradwell, A.R., Clark, R.J., Larson, D.R., Plevak, M.F., Dispenzieri, A. & Katzmann, J.A. (2005) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood, 106, 812817.
  • Ratliff, J., Nguyen, T. & Heiss, J. (2001) Root and spinal cord compression from methylmethacrylate vertebroplasty. Spine, 26, E300E302.
  • Reljanovic, M., Reichel, G., Rett, K., Lobisch, M., Schuette, K., Möller, W., Tritschler, H.J. & Mehnert, H. (1999) Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radical Research, 31, 171179.
  • Roglio, I., Giatti, S., Pesaresi, M., Bianchi, R., Cavaletti, G., Lauria, G., Garcia-Segura, L.M. & Melcangi, R.C. (2008) Neuroactive steroids and peripheral neuropathy. Brain research reviews, 57, 460469.
  • Saag, K.G., Shane, E., Boonen, S., Marin, F., Donley, D.W., Taylor, K.A., Dalsky, G.P. & Marcus, R. (2007) Teriparatide or alendronate in gluocorticoid-induced osteoporosis. New England Journal of Medicine, 357, 20282039.
  • Sallah, S., Husain, A., Wan, J., Vos, P. & Nguyen, N.P. (2004) The risk of venous thromboembolic disease in patients with monoclonal gammopathy of undetermined significance. Annals of Oncology, 15, 14901494.
  • Scheffler, N.M., Sheitel, P.L. & Lipton, M.N. (1991) Treatment of painful diabetic neuropathy with capsaicin 0.075%. Journal of the American Podiatric Medical Association, 81, 288293.
  • Shen, M.S. & Kim, Y.H. (2006) Vertebroplasty and kyphoplasty: treatment techniques for managing osteoporotic vertebral compression fractures. Bulletin of the NYU hospital for joint diseases, 64, 106113.
  • Simeonov, S., Pavlova, M., Mitkov, M., Mincheva, L. & Troev, D. (1997) Therapeutic efficacy of “Milgamma” in patients with painful diabetic neuropathy. Folia medica, 39, 510.
  • Singh, J., Dudley, Jr, A.W. & Kulig, K.A. (1990) Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting. Journal of Laboratory and Clinical Medicine, 116, 785789.
  • Srkalovic, G., Cameron, M.G., Rybicki, L., Deitcher, S.R., Kattke-Marchant, K. & Hussein, M.A. (2004) Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease. Cancer, 101, 558566.
  • Steck, A., Murray, N., Meier, C., Braun, P., Danoff, D., Finlayson, M. & Stewart, J. (1983) Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein. Neurology, 33, 1923.
  • Taylor, R.S., Taylor, R.J. & Fritzell, P. (2006) Balloon kyphoplasty and vertebroplasty for vertebral compression fractures: a comparative systematic review of efficacy and safety. Spine, 31, 27472755.
  • Tsavaris, N., Kopterides, P., Kosmas, C., Efthymiou, A., Skopelitis, H., Dimitrakopoulos, A., Pagouni, E., Pikazis, D., Zis, P.V. & Koufos, C. (2008) Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: a pilot study. Pain medicine, 9, 12091216.
  • Vachon, C.M., Kyle, R.A., Therneau, T.M., Foreman, B.J., Larson, D.R., Colby, C.L., Phelps, T.K., Dispenzieri, A., Kumar, S.K., Katzmann, J.A. & Rajkumar, S.V. (2009) Increased risk of monoclonal gammopathy of undetermined significance. Blood, 114, 785790.
  • Vondracek, P., Oslejskova, H., Kepak, T., Mazanek, P., Sterba, J., Rysava, M. & Gal, P. (2009) Efficacy of pregabalin in neuropathic pain in paediatric oncological patients. European journal of paediatric neurology, 13, 332336.
  • Wardlaw, D., Cummings, S.R., Meirhaeghe, J.V., Bastian, L., Tillman, J.B., Ranstam, J., Eastel, R., Shabe, P., Talmadge, K. & Boonen, S. (2009) Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomized controlled trial. Lancet, 373, 10161024.
  • Weiss, B.M., Abadie, J., Verma, P., Howard, R.S. & Kuehl, W.M. (2009) A monoclonal gammopathy precedes multiple myeloma in most patients. Blood, 113, 54185422.
  • Yaqub, B.A., Siddique, A. & Sulimani, R. (1992) Effects of methylcobalamin on diabetic neuropathy. Clinical Neurology and Neurosurgery, 94, 105111.
  • Yeung, K.B., Thomas, P.K. & King, R.H.M. (1991) The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinemia: comparative clinical, immunological and nerve biopsy findings. Journal of Neurology, 238, 383391.
  • Zaja, F., De Vita, S., Mazzaro, C., Sacco, S., Damiani, D., De Marchi, G., Michelutti, A., Baccarani, M., Fanin, R. & Ferraccioli, G. (2003) Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood, 101, 38273834.
  • Ziegler, D., Hanefeld, M., Ruhnau, K.J., Meissner, H.P., Lobisch, M., Schütte, K. & Gries, F.A. (1995) Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia, 38, 14251433.
  • Ziegler, D., Hanefeld, M., Ruhnau, K.J., Hasche, H., Lobisch, M., Schütte, K., Kerum, G. & Malessa, R. (1999) Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care, 22, 12961301.